We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Transplants Cure Incontinence

By HospiMedica staff writers
Posted on 12 Jun 2006
Stem cell transplantation can end incontinence caused by age or surgery, according to new research. More...


Scientists at the University of Innsbruck (Austria) took adult stem cells from a muscle biopsy, isolated myoblasts and fibroblasts from the biopsy material, and grew them in culture. When there were enough cells, the autologous fibroblasts were injected into the wall of critical sphincter muscles around the urethra to create scaffolding for the myoblasts that were also injected into the area.

The cells then performed their muscular tasks, giving new strength to the sphincters. The sphincter walls contracted better and the thickness of the urethra increased, as did the thickness of the rhambdosphincter. Incontinence scores and quality of life were improved. The procedure was performed in186 people, 123 of them women. Of that group, 156 were cured of incontinence. The results were reported at the American Urological Association (AUA) annual meeting in May 2006 in Atlanta (GA, USA).

"There have been more than a hundred proposed treatments for incontinence in these individuals,” said Hannes Strasser, M.D, "but all of them have limitations. The use of a person's own adult stem cells appears to overcome ethical issues regarding embryonic cells and, more importantly, they seem to work.”

Stem cell therapy is a part of a group of new techniques or technologies that rely on replacing diseased or dysfunctional cells with healthy, functioning ones. These new techniques are being applied experimentally to a wide range of human disorders, including many types of cancer, neurologic diseases such as Parkinson's disease and ALS (Lou Gehrig's disease), spinal cord injuries, and diabetes.



Related Links:
University of Innsbruck

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.